IBDEI0E8 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19052,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,19053,0)
 ;;=V10.43^^117^1108^11
 ;;^UTILITY(U,$J,358.3,19053,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19053,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,19053,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,19053,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,19054,0)
 ;;=V10.44^^117^1108^18
 ;;^UTILITY(U,$J,358.3,19054,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19054,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,19054,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,19054,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,19055,0)
 ;;=V10.81^^117^1108^2
 ;;^UTILITY(U,$J,358.3,19055,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19055,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,19055,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,19055,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,19056,0)
 ;;=V10.82^^117^1108^25
 ;;^UTILITY(U,$J,358.3,19056,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19056,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,19056,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,19056,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,19057,0)
 ;;=V10.83^^117^1108^31
 ;;^UTILITY(U,$J,358.3,19057,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19057,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,19057,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,19057,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,19058,0)
 ;;=V10.84^^117^1108^6
 ;;^UTILITY(U,$J,358.3,19058,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19058,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,19058,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,19058,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,19059,0)
 ;;=V10.85^^117^1108^3
 ;;^UTILITY(U,$J,358.3,19059,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19059,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,19059,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,19059,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,19060,0)
 ;;=V10.86^^117^1108^26
 ;;^UTILITY(U,$J,358.3,19060,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19060,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,19060,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,19060,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,19061,0)
 ;;=V10.88^^117^1108^16
 ;;^UTILITY(U,$J,358.3,19061,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19061,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,19061,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,19061,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,19062,0)
 ;;=238.0^^117^1109^1
 ;;^UTILITY(U,$J,358.3,19062,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19062,1,1,0)
 ;;=1^238.0
 ;;^UTILITY(U,$J,358.3,19062,1,8,0)
 ;;=8^Bone and Articular Cartilage
 ;;^UTILITY(U,$J,358.3,19062,2)
 ;;=^81953
 ;;^UTILITY(U,$J,358.3,19063,0)
 ;;=238.1^^117^1109^3
 ;;^UTILITY(U,$J,358.3,19063,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19063,1,1,0)
 ;;=1^238.1
 ;;^UTILITY(U,$J,358.3,19063,1,8,0)
 ;;=8^Connective and Oth Soft Tissue
 ;;^UTILITY(U,$J,358.3,19063,2)
 ;;=^267776
 ;;^UTILITY(U,$J,358.3,19064,0)
 ;;=238.2^^117^1109^17
 ;;^UTILITY(U,$J,358.3,19064,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19064,1,1,0)
 ;;=1^238.2
 ;;^UTILITY(U,$J,358.3,19064,1,8,0)
 ;;=8^Skin
 ;;^UTILITY(U,$J,358.3,19064,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,19065,0)
 ;;=238.3^^117^1109^2
 ;;^UTILITY(U,$J,358.3,19065,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19065,1,1,0)
 ;;=1^238.3
 ;;^UTILITY(U,$J,358.3,19065,1,8,0)
 ;;=8^Breast
 ;;^UTILITY(U,$J,358.3,19065,2)
 ;;=^81956
 ;;^UTILITY(U,$J,358.3,19066,0)
 ;;=238.4^^117^1109^15
 ;;^UTILITY(U,$J,358.3,19066,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19066,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,19066,1,8,0)
 ;;=8^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,19066,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,19067,0)
 ;;=238.5^^117^1109^6
 ;;^UTILITY(U,$J,358.3,19067,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19067,1,1,0)
 ;;=1^238.5
 ;;^UTILITY(U,$J,358.3,19067,1,8,0)
 ;;=8^Histiocytic and Mast Cells
 ;;^UTILITY(U,$J,358.3,19067,2)
 ;;=^267778
 ;;^UTILITY(U,$J,358.3,19068,0)
 ;;=238.6^^117^1109^14
 ;;^UTILITY(U,$J,358.3,19068,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19068,1,1,0)
 ;;=1^238.6
 ;;^UTILITY(U,$J,358.3,19068,1,8,0)
 ;;=8^Plasma Cells
 ;;^UTILITY(U,$J,358.3,19068,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,19069,0)
 ;;=238.71^^117^1109^4
 ;;^UTILITY(U,$J,358.3,19069,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19069,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,19069,1,8,0)
 ;;=8^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,19069,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,19070,0)
 ;;=238.72^^117^1109^7
 ;;^UTILITY(U,$J,358.3,19070,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19070,1,1,0)
 ;;=1^238.72
 ;;^UTILITY(U,$J,358.3,19070,1,8,0)
 ;;=8^Low Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,19070,2)
 ;;=^334028
 ;;^UTILITY(U,$J,358.3,19071,0)
 ;;=238.73^^117^1109^5
 ;;^UTILITY(U,$J,358.3,19071,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19071,1,1,0)
 ;;=1^238.73
 ;;^UTILITY(U,$J,358.3,19071,1,8,0)
 ;;=8^High Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,19071,2)
 ;;=^334029
 ;;^UTILITY(U,$J,358.3,19072,0)
 ;;=238.74^^117^1109^9
 ;;^UTILITY(U,$J,358.3,19072,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19072,1,1,0)
 ;;=1^238.74
 ;;^UTILITY(U,$J,358.3,19072,1,8,0)
 ;;=8^Myelody Synd w/ 5q Deletion
 ;;^UTILITY(U,$J,358.3,19072,2)
 ;;=^334030
 ;;^UTILITY(U,$J,358.3,19073,0)
 ;;=238.75^^117^1109^10
 ;;^UTILITY(U,$J,358.3,19073,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19073,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,19073,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,19073,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,19074,0)
 ;;=238.76^^117^1109^11
 ;;^UTILITY(U,$J,358.3,19074,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19074,1,1,0)
 ;;=1^238.76
 ;;^UTILITY(U,$J,358.3,19074,1,8,0)
 ;;=8^Myelofibrosis w/Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,19074,2)
 ;;=^334032
 ;;^UTILITY(U,$J,358.3,19075,0)
 ;;=238.77^^117^1109^16
 ;;^UTILITY(U,$J,358.3,19075,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19075,1,1,0)
 ;;=1^238.77
 ;;^UTILITY(U,$J,358.3,19075,1,8,0)
 ;;=8^Post Transp Lymphoprolif d/o PTLD
 ;;^UTILITY(U,$J,358.3,19075,2)
 ;;=^336526
 ;;^UTILITY(U,$J,358.3,19076,0)
 ;;=238.79^^117^1109^12
 ;;^UTILITY(U,$J,358.3,19076,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19076,1,1,0)
 ;;=1^238.79
 ;;^UTILITY(U,$J,358.3,19076,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue
 ;;^UTILITY(U,$J,358.3,19076,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,19077,0)
 ;;=238.8^^117^1109^13
 ;;^UTILITY(U,$J,358.3,19077,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19077,1,1,0)
 ;;=1^238.8
 ;;^UTILITY(U,$J,358.3,19077,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue NEC
 ;;^UTILITY(U,$J,358.3,19077,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,19078,0)
 ;;=238.9^^117^1109^8
 ;;^UTILITY(U,$J,358.3,19078,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19078,1,1,0)
 ;;=1^238.9
 ;;^UTILITY(U,$J,358.3,19078,1,8,0)
 ;;=8^Lymph/Hematopoietic Tissue NOS
 ;;^UTILITY(U,$J,358.3,19078,2)
 ;;=^267780
 ;;^UTILITY(U,$J,358.3,19079,0)
 ;;=239.0^^117^1110^5
 ;;^UTILITY(U,$J,358.3,19079,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19079,1,1,0)
 ;;=1^239.0
 ;;^UTILITY(U,$J,358.3,19079,1,8,0)
 ;;=8^Digestive Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19079,2)
 ;;=^267781
 ;;^UTILITY(U,$J,358.3,19080,0)
 ;;=239.1^^117^1110^11
 ;;^UTILITY(U,$J,358.3,19080,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19080,1,1,0)
 ;;=1^239.1
 ;;^UTILITY(U,$J,358.3,19080,1,8,0)
 ;;=8^Respiratory Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19080,2)
 ;;=^267782
 ;;^UTILITY(U,$J,358.3,19081,0)
 ;;=239.2^^117^1110^2
 ;;^UTILITY(U,$J,358.3,19081,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19081,1,1,0)
 ;;=1^239.2
 ;;^UTILITY(U,$J,358.3,19081,1,8,0)
 ;;=8^Bone,Soft Tissue,Skin Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19081,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,19082,0)
 ;;=239.3^^117^1110^4
 ;;^UTILITY(U,$J,358.3,19082,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19082,1,1,0)
 ;;=1^239.3
 ;;^UTILITY(U,$J,358.3,19082,1,8,0)
 ;;=8^Breast Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19082,2)
 ;;=^81977
 ;;^UTILITY(U,$J,358.3,19083,0)
 ;;=239.4^^117^1110^1
 ;;^UTILITY(U,$J,358.3,19083,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19083,1,1,0)
 ;;=1^239.4
 ;;^UTILITY(U,$J,358.3,19083,1,8,0)
 ;;=8^Bladder Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19083,2)
 ;;=^81975
 ;;^UTILITY(U,$J,358.3,19084,0)
 ;;=239.5^^117^1110^9
 ;;^UTILITY(U,$J,358.3,19084,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19084,1,1,0)
 ;;=1^239.5
 ;;^UTILITY(U,$J,358.3,19084,1,8,0)
 ;;=8^Oth Genitourinary Org Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19084,2)
 ;;=^267784
 ;;^UTILITY(U,$J,358.3,19085,0)
 ;;=239.6^^117^1110^3
 ;;^UTILITY(U,$J,358.3,19085,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19085,1,1,0)
 ;;=1^239.6
 ;;^UTILITY(U,$J,358.3,19085,1,8,0)
 ;;=8^Brain Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19085,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,19086,0)
 ;;=239.7^^117^1110^6
 ;;^UTILITY(U,$J,358.3,19086,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19086,1,1,0)
 ;;=1^239.7
 ;;^UTILITY(U,$J,358.3,19086,1,8,0)
 ;;=8^Endocrine/Nerv Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19086,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,19087,0)
 ;;=239.81^^117^1110^12
 ;;^UTILITY(U,$J,358.3,19087,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19087,1,1,0)
 ;;=1^239.81
 ;;^UTILITY(U,$J,358.3,19087,1,8,0)
 ;;=8^Retina/Choroid Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,19087,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,19088,0)
 ;;=239.89^^117^1110^7
 ;;^UTILITY(U,$J,358.3,19088,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19088,1,1,0)
 ;;=1^239.89
 ;;^UTILITY(U,$J,358.3,19088,1,8,0)
 ;;=8^Neoplasm,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,19088,2)
 ;;=^338225
 ;;^UTILITY(U,$J,358.3,19089,0)
 ;;=239.9^^117^1110^8
 ;;^UTILITY(U,$J,358.3,19089,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,19089,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,19089,1,8,0)
 ;;=8^Neoplasm,Unspec Site 
